ClinicalTrials.govpublic full text
Functional Brain Imaging of Medication Treatment Response in Mild Alzheimer's Disease Patients
alzheimer's disease, fmri, functional neuroimaging, allosteric nicotinic receptor modulation, acetylcholinesterase inhibition, head to head, dose escalation, biomarker, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1010322
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.